Royce & Associates’s Sanofi SNY Stock Holding History

Royce & Associates’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-1,000	Closed	-$52K	–	1476
2013 Q2	$52K	Buy	+1,000	New	+$53.3K	﹤0.01%	1380

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Montag & Caldwell Atlanta, Georgia $457M AUM 20.19% 1-Year Est. Return

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Royce & Associates's SNY Position: Q3 2013 in Review

Royce & Associates sold out of Sanofi (SNY) in Q3 2013, closing a stake of 1,000 shares — an estimated $52K sold.

Royce & Associates first reported a position in SNY in Q2 2013 and held it in 1 quarter. The position peaked at $52K in Q2 2013. 456 funds tracked by Wall St. Rank hold SNY as of Q3 2013.

Royce & Associates reported no remaining Sanofi position as of Q3 2013 after selling out during the quarter.
Royce & Associates sold 1,000 Sanofi shares in Q3 2013, an estimated $52K.
Royce & Associates first reported a position in Sanofi in Q2 2013 and held it in 1 quarter.
Royce & Associates's Sanofi position peaked at $52K in Q2 2013.
456 funds tracked by Wall St. Rank held Sanofi as of Q3 2013.

Based on Royce & Associates's 13F filing for Q3 2013, filed 12 Nov 2013.